TGFB1 and Hepatic fibrosis: However, the hepatic fibrosis/HSC activation pathway was highly significant for the TGF-β data set (-log[P value], 5.6), whereas treatment with PDGF-BB was not as dominant as TGF-β for this domain (-log[P value], 2.686) (Figure 1D).